In May 2015, the Food and Drug Administration (FDA) warned doctors and patients that certain types of type 2 diabetes drugs, including Invokana (canagliflozin), could cause diabetic ketoacidosis (DKA) in some patients. This is a serious condition in which the blood becomes too acidic, and…
While flying cars may still remain absent from our city streets, the future of driverless cars is getting one step closer each day. It seems to be a bit of a rocky road, however, as accidents involving Google’s driverless cars have been in the headlines…
Over 1,900 Xarelto lawsuits are currently pending in state and federal courts, with plaintiffs claiming that the anticoagulant caused serious injuries, including gastrointestinal bleeding, blood clots, stroke, and heart attack. Within just a couple years of being on the market, Xarelto (rivaroxaban) was associated with…
The Press conference from last week has been posted: Abuse of children and the continued silence by the offenders needs to be prevented. If you suffered, saw, or suspected such events, it is important to know that there is help out there.
More than 60 lawsuits have been filed against GlaxoSmithKline, claiming the company’s anti-nausea drug Zofran causes birth defects. In the wake of a federal panel’s decision to send the claims to Boston, these families await new developments in their cases with a mix of anxiety and…
A San Francisco bicyclist who was killed in a crash with a MUNI bus earlier this month has been recently identified by the San Francisco Medical Examiner’s Office (information on the name and identification of this man can be found here). First, I want to extend…
The U.S. Food and Drug Administration (FDA) has strengthened the warning for the Type II diabetes drug canagliflozin (Invokana, Invokamet) to include the increased risk of bone fractures and added new information about decreased bone mineral density. In 2013, Invokana became the first sodium-glucose co-transporter…
The FDA released another safety warning concerning type 2 diabetes medication Invokana (canagliflozin). Back in May 2015, the administration warned doctors and patients of the potential for Invokana to increase risk of diabetic ketoacidosis (DKA), a condition in which the blood becomes too acidic. Without…
Two of the “best and brightest” Volkswagen engineers who discovered that VW wouldn’t be able to deliver a clean diesel engine that would meet U.S. Environmental Protection Agency (EPA) standards are in the middle of a company probe into the installation of software designed to…
In April 2015, an FDA advisory panel voted to include new safety information about potential heart failure side effects on the label of the diabetes drug Onglyza (saxaglipton). This was after the panel reviewed the results of the “SAVOR” trial, in which researchers found that…